←Back to Expert Scholars
Translational Medicine / 转化医学HER2 Ultra-Low
Javier Cortes
MD, PhD
🏢IBCC Barcelona🌐Spain
Head, International Breast Cancer Center
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Javier Cortes led key DESTINY-Breast trials establishing trastuzumab deruxtecan as standard for HER2-low disease. His work underpins recognition of HER2-ultralow as a distinct therapeutic category. He heads the International Breast Cancer Center in Barcelona.
Share:
🧪Research Fields 研究领域
HER2 ADCs
DESTINY-Breast trials
Metastatic breast cancer
HER2-low classification
Translational research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Javier Cortes 的研究动态
Follow Javier Cortes's research updates
留下邮箱，当我们发布与 Javier Cortes（IBCC Barcelona）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment